Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-18-117073
Filing Date
2018-04-13
Accepted
2018-04-13 17:31:37
Documents
8
Period of Report
2018-04-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A d518905dpre14a.htm PRE 14A 636108
2 GRAPHIC g518905g11y77.jpg GRAPHIC 26592
3 GRAPHIC g518905g21j11.jpg GRAPHIC 24658
4 GRAPHIC g518905g38r58.jpg GRAPHIC 25687
5 GRAPHIC g518905g56z83.jpg GRAPHIC 16586
6 GRAPHIC g518905g57f70.jpg GRAPHIC 22487
7 GRAPHIC g518905g61c12.jpg GRAPHIC 58102
8 GRAPHIC g518905g98q07.jpg GRAPHIC 27964
  Complete submission text file 0001193125-18-117073.txt   916242
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36199 | Film No.: 18755140
SIC: 2834 Pharmaceutical Preparations